| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,234 | 0,286 | 11:10 | |
| 0,252 | 0,270 | 08:55 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ISLAND PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 31.08. | ISLAND PHARMACEUTICALS LIMITED: Pivotal Marburg data secured for Galidesivir FDA pathway | 1 | ASX | ||
| 26.08. | Island Pharmaceuticals Ltd Full Year Loss Widens | 1 | RTTNews | ||
| 26.08. | ISLAND PHARMACEUTICALS LIMITED: Appendix 4G and Corporate Governance Statement | - | ASX | ||
| 26.08. | ISLAND PHARMACEUTICALS LIMITED: Annual Report to shareholders | - | ASX | ||
| 26.08. | ISLAND PHARMACEUTICALS LIMITED: Preliminary Final Report | 1 | ASX | ||
| 21.08. | Daily Special: Rural Funds Group, Nyrada, Liberty Metals, Noble Helium, Island Pharmaceuticals | 4 | Finance News Network | ||
| 21.08. | Island Pharmaceuticals Builds Galidesivir Inventory for Outbreak Response | 1 | smallcaps.com.au | ||
| 21.08. | ISLAND PHARMACEUTICALS LIMITED: Island boosts Galidesivir supply as Ebola surges | - | ASX | ||
| 13.08. | ISLAND PHARMACEUTICALS LIMITED: Date of AGM & Closing Date for Director Nominations | 1 | ASX | ||
| 12.08. | ISLAND PHARMACEUTICALS LIMITED: Cleansing Notice | 1 | ASX | ||
| 12.08. | ISLAND PHARMACEUTICALS LIMITED: Application for quotation of securities - ILA | 1 | ASX | ||
| 07.08. | ISLAND PHARMACEUTICALS LIMITED: Investor presentation | 1 | ASX | ||
| 30.07. | ISLAND PHARMACEUTICALS LIMITED: Quarterly Appendix 4C and Activities Report | - | ASX | ||
| 28.07. | Biocurious: Post Germageddon, Island Pharma will keep the US ticking over | 1 | Stockhead | ||
| 27.07. | Island Pharmaceuticals (ASX:ILA) walks into TechKnow with Marburg, Ebola and ISLA-101 all live | 1 | Stocks Down Under | ||
| 27.07. | ISLAND PHARMACEUTICALS LIMITED: Investor Presentation - TechKnow Invest Roadshow | - | ASX | ||
| 13.07. | ISLAND PHARMACEUTICALS LIMITED: Notification regarding unquoted securities - ILA | - | ASX | ||
| 13.07. | ISLAND PHARMACEUTICALS LIMITED: Notification regarding unquoted securities - ILA | - | ASX | ||
| 13.07. | ISLAND PHARMACEUTICALS LIMITED: Notification regarding unquoted securities - ILA | - | ASX | ||
| 13.07. | ISLAND PHARMACEUTICALS LIMITED: Notification regarding unquoted securities - ILA | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IM CANNABIS CORP | 4,200 | 0,00 % | IM Cannabis Stock Surges 247% | ||
| BAYER | 48,455 | -1,94 % | Bayer schließt Kapitallösung für Verhütungsgeschäft ab | ||
| NOVO NORDISK | 35,740 | -5,01 % | Novo will in der Medikamentenentwicklung Claude von Anthropic einsetzen | DJ Novo will in der Medikamentenentwicklung Claude von Anthropic einsetzen
Von Adria Calatayud
DOW JONES--Novo will die Entwicklung neuer Medikamente mit Hilfe von Künstlicher Intelligenz (KI)... ► Artikel lesen | |
| KARDIGAN | 16,620 | 0,00 % | Citi's U.S. Consumer Cards Business To Buy Kard Financial For Undisclosed Terms | WASHINGTON (dpa-AFX) - Banking major Citigroup Inc. (C) announced late Thursday that its U.S. Consumer Cards business has agreed to acquire Kard Financial, a commerce media and rewards platform.... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 17,150 | 0,00 % | Generate Biomedicines auf der H.C. Wainwright Konferenz: Plattform-Strategie im Fokus | ||
| MERCK KGAA | 131,05 | -1,22 % | Community-Rückblick: "Moderna wäre um min. 50% gestiegen, BioNTech bisher nicht mal 2%. That's it!" | © Foto: Julia Cebella - dpaNeue Onkologie-Daten sorgen bei BioNTech für Diskussionen: Warum reagiert die Aktie trotz guter Studienergebnisse kaum? Die wO User Diskutieren über Pipeline, Bewertung und... ► Artikel lesen | |
| LB PHARMACEUTICALS | 42,370 | 0,00 % | LB Pharmaceuticals Appoints Susan Kozauer As CMO | ||
| ETON PHARMACEUTICALS | 55,48 | 0,00 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| APNIMED | 29,020 | 0,00 % | Apnimed, Inc.: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update | U.S. Food and Drug Administration ("FDA") Accepted the NDA for AD109, with a proposed proprietary name Oxnimbi- and assigned a PDUFA target action date of February 28,- 2027 If approved, Oxnimbi... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,600 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm (dibutepinephrine) Sublingual Film | Resubmission supported by positive topline human factors and pharmacokinetic (PK) study results announced in August 2026FDA will determine the resubmission classification and establish the applicable... ► Artikel lesen | |
| DATAMEDS AI | 3,750 | 0,00 % | DataMEDS AI, Inc.: DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked | TAMPA, FL / ACCESS Newswire / September 18, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure... ► Artikel lesen | |
| OMNIAB | 4,470 | 0,00 % | Veraxa Biotech AG: VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb | VXA-222 advances into next phase at VERAXAZURICH, SWITZERLAND, July 27, 2026 --
VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA" or the "Company"), an emerging leader in designing novel cancer therapies... ► Artikel lesen | |
| ATRIUM THERAPEUTICS | 8,950 | 0,00 % | Atrium Therapeutics Reports Second Quarter 2026 Financial Results | -- IND clearance for ATR 1072 and launch of Corventis Phase 1/2 trial in PRKAG2 syndrome --
-- Achieved second milestone payment under global cardiovascular collaboration... ► Artikel lesen | |
| MEDICINOVA | 3,305 | 0,00 % | Biotech Stocks At 52-Week Highs - MediciNova +8%, Revvity +8%, 10x Genomics +6%, Telix Pharmaceuticals +9%, Schrodinger Inc. +12% | CANBERA (dpa-AFX) - The following biotech stocks reached a 52-week high on September 15, 2026, driven by the gain on certain clinical or financial results.MediciNova Inc. (MNOV)MediciNova functions... ► Artikel lesen | |
| PFIZER | 24,035 | 0,00 % | KAUFWELLE bei Pfizer: +17,3% Abstand vom 52-Wochen-Tief - Einstieg jetzt oder nie? |